Recital 4, Regulation (EU) 2022/1373

In forcesince 5 Aug 2022

On 21 February 2020, the applicant also made a request to the Commission for the protection of proprietary data for an in vitro mammalian cell micronucleus test [Nemysis Limited (2019, unpublished).], an in vitro mammalian cell gene mutation test using the thymidine kinase gene [Nemysis Limited (2019, unpublished).], and a 90-day oral toxicity study in rodents [Nemysis Limited (2019, unpublished).], submitted in support of the application.